1. FRAX and ethnicity

   • J. A. Kanis
   • C. Cooper
   • on behalf of the International Osteoporosis Foundation

   Editorial 04 September 2020 Pages: 2063 - 2067

   

2. Racial disparities, FRAX, and the care of patients with osteoporosis

   • E.M. Lewiecki
   • N.C. Wright
   • A.J. Singer

   Editorial 26 September 2020 Pages: 2069 - 2071

3. Core principles for fracture prevention: North American Consensus from the National Osteoporosis Foundation, Osteoporosis Canada, and Academia Nacional de Medicina de Mexico

   • E.M. Lewiecki
   • N. Binkley
   • S.N. Morin

   Consensus Statement 16 July 2020 Pages: 2073 - 2076

4. IQ driving QI: the Asia Pacific Consortium on Osteoporosis (APCO): an innovative and collaborative initiative to improve osteoporosis care in the Asia Pacific

   • M. Chandran
   • S.K. Bhadada
   • on behalf of the Asia Pacific Consortium on Osteoporosis

   Viewpoints Open access 19 June 2020 Pages: 2077 - 2081

5. Association of orthogeriatric care models with evaluation and treatment of osteoporosis: a systematic review and meta-analysis

   • L. Van Camp
   • M. Dejaeger
   • M. R. Laurent

   Review 27 June 2020 Pages: 2083 - 2092

   

6. Persistence and adherence to parenteral osteoporosis therapies: a systematic review

   • G. Koller
   • V. Goetz
   • C. Ye

   Review 01 July 2020 Pages: 2093 - 2102

   

7. Determinants of imminent fracture risk in postmenopausal women with osteoporosis

   • R. L. Barron
   • G. Oster
   • D. Weycker

   Original Article Open access 01 July 2020 Pages: 2103 - 2111

   

8. Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort

   • G. Adami
   • D. Gatti
   • A. Fassio

   Original Article 01 July 2020 Pages: 2113 - 2122

   

9. Ten-year fracture risk predicted by proximal femur Hounsfield units

   • D. L. Christensen
   • K. E. Nappo
   • S. M. Tintle

   Original Article 27 June 2020 Pages: 2123 - 2130

   

10. Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study

    • A. Shin
    • E.H. Park
    • E.H. Kang

    Original Article 08 June 2020 Pages: 2131 - 2139

    

11. Effect of high-dose vitamin D supplementation on peripheral arterial calcification: secondary analysis of a randomized controlled trial

    • E. O. Billington
    • L. A. Burt
    • D. A. Hanley

    Original Article 15 June 2020 Pages: 2141 - 2150

    

12. Coexistence of osteoporosis and atherosclerosis in pheochromocytoma: new insights into its long-term management

    • M. Yokomoto-Umakoshi
    • H. Umakoshi
    • the Q-AND-A study group

    Original Article 02 July 2020 Pages: 2151 - 2160

    

13. Impact of an orthogeriatrician on length of stay of elderly patient with hip fracture

    • C. Aletto
    • R. Aicale
    • N. Maffulli

    Original Article 22 June 2020 Pages: 2161 - 2166

14. Traumatic fractures in China from 2012 to 2014: a National Survey of 512,187 individuals

    • H. Lv
    • W. Chen
    • Y. Zhang

    Original Article 10 June 2020 Pages: 2167 - 2178

15. Adherence to the dietary approaches to stop hypertension (DASH) dietary pattern and osteoporosis risk in postmenopausal Iranian women

    • Z. Shahriarpour
    • B. Nasrabadi
    • B. Rashidkhani

    Original Article 18 June 2020 Pages: 2179 - 2188

    

16. Using opportunistic screening with abdominal CT to identify osteoporosis and osteopenia in patients with diabetes

    • R.K. Jain
    • E. Lee
    • T. Vokes

    Original Article 05 July 2020 Pages: 2189 - 2196

    

17. An in-depth study of the associations between osteoarthritis- and osteoporosis-related phenotypes at different skeletal locations

    • M. Kasher
    • F.M.K. Williams
    • G. Livshits

    Original Article 16 June 2020 Pages: 2197 - 2208

    

18. The micro-structural analysis of lumbar vertebrae in alcoholic liver cirrhosis

    • J. Jadzic
    • D. Cvetkovic
    • D. Djonic

    Original Article 24 June 2020 Pages: 2209 - 2217

    

19. Bone microstructure of adult patients with non-surgical hypoparathyroidism assessed by high-resolution peripheral quantitative computed tomography

    • J. Liu
    • S. Chen
    • W. Xia

    Original Article 04 July 2020 Pages: 2219 - 2230

    

20. A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab

    • M. R. McClung
    • M. A. Bolognese
    • A. Grauer

    Original Article Open access 04 July 2020 Pages: 2231 - 2241

    

21. Effects of progesterone therapy on serum sclerostin levels in healthy menopausal women: a 3-month randomized, placebo-controlled clinical trial

    • Y. B. Yang
    • A. Goshtasebi
    • J. C. Prior

    Original Article 20 June 2020 Pages: 2243 - 2250

    

22. A novel de novo heterozygous ALPL nonsense mutation associated with adult hypophosphatasia

    • L. Martins
    • E.L. dos Santos
    • F.H. Nociti Jr

    Short Communication 23 June 2020 Pages: 2251 - 2257

    

23. Persistent hyperparathyroidism due to mediastinal parathyroid adenoma treated with selective arterial embolization with embosphere: first case in the literature

    • G. Yuce
    • N.C. Seyrek

    Case Report 05 June 2020 Pages: 2259 - 2262

    

24. Multiple ipsilateral femoral stress fractures in a patient taking denosumab for osteoporosis—a case report

    • H. I. Piponov
    • J. M. Goldstein
    • G. M. Eisenberg

    Case Report 20 June 2020 Pages: 2263 - 2267

    

25. Correction to Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials

    • A. Mott
    • T. Bradley
    • D. J. Torgerson

    Correction 23 September 2020 Pages: 2269 - 2270